Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012201136> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2012201136 endingPage "1262" @default.
- W2012201136 startingPage "1249" @default.
- W2012201136 abstract "The 10-year cumulative experiences of five year survivals of patients entered into a successful phase II specific active tumor-associated antigen (TAA) immunotherapy trial, a successful phase III specific active immunotherapy trial A and of patients from centers with acceptable protocol violation levels of an unsuccessful specific active immunotherapy trial B are evaluated. Here the authors report the efficacy of specific active TAA immunotherapy when the protocol is adhered to strictly, where the induction of cell-mediated immunity to TAA indicated a successful adherence to the protocol rather than the strategic result when centers from the third trial with major violations are included. The authors repeat here a summary of each of the three separate trials, each of the three trials having been reported elsewhere in their entirety, so that these total results may be compared to the present analysis. The survival experiences of a total of 234 lung cancer Stage I and Stage II patients, including all violations, from centers in northern New York, northern New Jersey, western Pennsylvania and eastern Canada show a statistically valid (P = 0.0002) 5-year survival difference between the control groups (receiving adjuvant alone or no treatment) at 49% survival and the specific active immunotherapy groups at 69% survival. The best promise of specific active immunotherapy alone in an adjunctive treatment setting is with early stage lung cancer. In addition to tests which monitor the effect of TAA immunotherapy induction of long-lasting cell-mediated immunity, tests (monoclonal antibody-derived epitope enzyme immunoassays) were developed to monitor specific, early antibody rises in the bloodstream (circulating humoral immunity)." @default.
- W2012201136 created "2016-06-24" @default.
- W2012201136 creator A5018400521 @default.
- W2012201136 creator A5031279634 @default.
- W2012201136 creator A5033132384 @default.
- W2012201136 creator A5050262253 @default.
- W2012201136 creator A5065673029 @default.
- W2012201136 date "1987-09-15" @default.
- W2012201136 modified "2023-10-05" @default.
- W2012201136 title "Adjuvant specific active lung cancer immunotherapy trials. Tumor-associated antigens" @default.
- W2012201136 cites W1985981664 @default.
- W2012201136 cites W2008068313 @default.
- W2012201136 cites W2023252936 @default.
- W2012201136 doi "https://doi.org/10.1002/1097-0142(19870915)60:6<1249::aid-cncr2820600616>3.0.co;2-i" @default.
- W2012201136 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2441838" @default.
- W2012201136 hasPublicationYear "1987" @default.
- W2012201136 type Work @default.
- W2012201136 sameAs 2012201136 @default.
- W2012201136 citedByCount "46" @default.
- W2012201136 countsByYear W20122011362012 @default.
- W2012201136 countsByYear W20122011362013 @default.
- W2012201136 countsByYear W20122011362014 @default.
- W2012201136 countsByYear W20122011362015 @default.
- W2012201136 crossrefType "journal-article" @default.
- W2012201136 hasAuthorship W2012201136A5018400521 @default.
- W2012201136 hasAuthorship W2012201136A5031279634 @default.
- W2012201136 hasAuthorship W2012201136A5033132384 @default.
- W2012201136 hasAuthorship W2012201136A5050262253 @default.
- W2012201136 hasAuthorship W2012201136A5065673029 @default.
- W2012201136 hasBestOaLocation W20122011361 @default.
- W2012201136 hasConcept C121608353 @default.
- W2012201136 hasConcept C126322002 @default.
- W2012201136 hasConcept C143998085 @default.
- W2012201136 hasConcept C147483822 @default.
- W2012201136 hasConcept C203014093 @default.
- W2012201136 hasConcept C2776256026 @default.
- W2012201136 hasConcept C2777701055 @default.
- W2012201136 hasConcept C2777863537 @default.
- W2012201136 hasConcept C2779616870 @default.
- W2012201136 hasConcept C2780674031 @default.
- W2012201136 hasConcept C535046627 @default.
- W2012201136 hasConcept C71924100 @default.
- W2012201136 hasConceptScore W2012201136C121608353 @default.
- W2012201136 hasConceptScore W2012201136C126322002 @default.
- W2012201136 hasConceptScore W2012201136C143998085 @default.
- W2012201136 hasConceptScore W2012201136C147483822 @default.
- W2012201136 hasConceptScore W2012201136C203014093 @default.
- W2012201136 hasConceptScore W2012201136C2776256026 @default.
- W2012201136 hasConceptScore W2012201136C2777701055 @default.
- W2012201136 hasConceptScore W2012201136C2777863537 @default.
- W2012201136 hasConceptScore W2012201136C2779616870 @default.
- W2012201136 hasConceptScore W2012201136C2780674031 @default.
- W2012201136 hasConceptScore W2012201136C535046627 @default.
- W2012201136 hasConceptScore W2012201136C71924100 @default.
- W2012201136 hasIssue "6" @default.
- W2012201136 hasLocation W20122011361 @default.
- W2012201136 hasLocation W20122011362 @default.
- W2012201136 hasOpenAccess W2012201136 @default.
- W2012201136 hasPrimaryLocation W20122011361 @default.
- W2012201136 hasRelatedWork W1999331099 @default.
- W2012201136 hasRelatedWork W2030612376 @default.
- W2012201136 hasRelatedWork W2129072649 @default.
- W2012201136 hasRelatedWork W2135979959 @default.
- W2012201136 hasRelatedWork W2990680987 @default.
- W2012201136 hasRelatedWork W2996772275 @default.
- W2012201136 hasRelatedWork W3032053889 @default.
- W2012201136 hasRelatedWork W4250535920 @default.
- W2012201136 hasRelatedWork W4323043461 @default.
- W2012201136 hasRelatedWork W4367182053 @default.
- W2012201136 hasVolume "60" @default.
- W2012201136 isParatext "false" @default.
- W2012201136 isRetracted "false" @default.
- W2012201136 magId "2012201136" @default.
- W2012201136 workType "article" @default.